Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A Stromal Cell-Derived Factor 1α Analogue Improves Endothelial Cell Function in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.

Guo C, Goodwin A, Buie JNJ, Cook J, Halushka P, Argraves K, Zingarelli B, Zhang X, Wang L, Fan H.

Mol Med. 2016 Sep;22:115-123. doi: 10.2119/molmed.2015.00240. Epub 2016 Mar 18.

2.

FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.

Yu H, Herbert BA, Valerio M, Yarborough L, Hsu LC, Argraves KM.

Lipids Health Dis. 2015 Jul 4;14:66. doi: 10.1186/s12944-015-0057-7.

3.

Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.

Yu H, Sun C, Argraves KM.

J Periodontal Res. 2016 Feb;51(1):38-49. doi: 10.1111/jre.12276. Epub 2015 Apr 20.

4.

Fibulin-1 suppresses endothelial to mesenchymal transition in the proximal outflow tract.

Harikrishnan K, Cooley MA, Sugi Y, Barth JL, Rasmussen LM, Kern CB, Argraves KM, Argraves WS.

Mech Dev. 2015 May;136:123-32. doi: 10.1016/j.mod.2014.12.005. Epub 2015 Jan 6.

5.

The role of sphingosine-1-phosphate in endothelial barrier function.

Wilkerson BA, Argraves KM.

Biochim Biophys Acta. 2014 Oct;1841(10):1403-1412. doi: 10.1016/j.bbalip.2014.06.012. Epub 2014 Jul 5. Review.

6.

Cubilin maintains blood levels of HDL and albumin.

Aseem O, Smith BT, Cooley MA, Wilkerson BA, Argraves KM, Remaley AT, Argraves WS.

J Am Soc Nephrol. 2014 May;25(5):1028-36. doi: 10.1681/ASN.2013060671. Epub 2013 Dec 19.

8.

Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation.

Zyblewski SC, Argraves WS, Graham EM, Slate EH, Atz AM, Bradley SM, McQuinn TC, Wilkerson BA, Wing SB, Argraves KM.

Pediatr Cardiol. 2012 Oct;33(7):1154-9. doi: 10.1007/s00246-012-0274-z. Epub 2012 Mar 13.

9.

Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation.

Bohonowych JE, Peng S, Gopal U, Hance MW, Wing SB, Argraves KM, Lundgren K, Isaacs JS.

BMC Cancer. 2011 Dec 15;11:520. doi: 10.1186/1471-2407-11-520.

10.

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.

Argraves KM, Sethi AA, Gazzolo PJ, Wilkerson BA, Remaley AT, Tybjaerg-Hansen A, Nordestgaard BG, Yeatts SD, Nicholas KS, Barth JL, Argraves WS.

Lipids Health Dis. 2011 May 9;10:70. doi: 10.1186/1476-511X-10-70.

11.

Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis.

Argraves KM, Wilkerson BA, Argraves WS.

World J Biol Chem. 2010 Oct 26;1(10):291-7. doi: 10.4331/wjbc.v1.i10.291.

12.

Fibulin-1 and fibrinogen in human atherosclerotic lesions.

Argraves WS, Tanaka A, Smith EP, Twal WO, Argraves KM, Fan D, Haudenschild CC.

Histochem Cell Biol. 2009 Nov;132(5):559-65. doi: 10.1007/s00418-009-0628-7. Epub 2009 Aug 20.

PMID:
19693531
13.

VEGF-mediated fusion in the generation of uniluminal vascular spheroids.

Gentile C, Fleming PA, Mironov V, Argraves KM, Argraves WS, Drake CJ.

Dev Dyn. 2008 Oct;237(10):2918-25. doi: 10.1002/dvdy.21720.

14.

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.

Argraves KM, Gazzolo PJ, Groh EM, Wilkerson BA, Matsuura BS, Twal WO, Hammad SM, Argraves WS.

J Biol Chem. 2008 Sep 5;283(36):25074-81. doi: 10.1074/jbc.M801214200. Epub 2008 Jul 7.

15.

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.

Argraves KM, Argraves WS.

J Lipid Res. 2007 Nov;48(11):2325-33. Epub 2007 Aug 13. Review.

16.

Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis.

Argraves KM, Wilkerson BA, Argraves WS, Fleming PA, Obeid LM, Drake CJ.

J Biol Chem. 2004 Nov 26;279(48):50580-90. Epub 2004 Sep 17.

17.

Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy.

Taha TA, Argraves KM, Obeid LM.

Biochim Biophys Acta. 2004 Jun 1;1682(1-3):48-55. Review.

PMID:
15158755
18.

Sphingolipids in vascular biology.

Argraves KM, Obeid LM, Hannun YA.

Adv Exp Med Biol. 2002;507:439-44. Review. No abstract available.

PMID:
12664623
19.

Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions.

Mikhailenko I, Battey FD, Migliorini M, Ruiz JF, Argraves K, Moayeri M, Strickland DK.

J Biol Chem. 2001 Oct 19;276(42):39484-91. Epub 2001 Aug 15.

20.

Enzymes of sphingolipid metabolism: from modular to integrative signaling.

Hannun YA, Luberto C, Argraves KM.

Biochemistry. 2001 Apr 24;40(16):4893-903. Review.

PMID:
11305904
21.

Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms.

Mikhailenko I, Considine W, Argraves KM, Loukinov D, Hyman BT, Strickland DK.

J Cell Sci. 1999 Oct;112 ( Pt 19):3269-81.

22.

Identification of chicken and C. elegans fibulin-1 homologs and characterization of the C. elegans fibulin-1 gene.

Barth JL, Argraves KM, Roark EF, Little CD, Argraves WS.

Matrix Biol. 1998 Dec;17(8-9):635-46.

PMID:
9923656
23.

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.

Argraves KM, Kozarsky KF, Fallon JT, Harpel PC, Strickland DK.

J Clin Invest. 1997 Nov 1;100(9):2170-81.

25.

The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.

Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gåfvels M, Kozarsky KF, Chappell DA, Strauss JF 3rd, Strickland DK.

J Biol Chem. 1995 Nov 3;270(44):26550-7.

26.

Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100.

Stefansson S, Chappell DA, Argraves KM, Strickland DK, Argraves WS.

J Biol Chem. 1995 Aug 18;270(33):19417-21.

27.

An overview of the structure and function of glycoprotein 330, a receptor related to the alpha 2-macroglobulin receptor.

Kounnas MZ, Stefansson S, Loukinova E, Argraves KM, Strickland DK, Argraves WS.

Ann N Y Acad Sci. 1994 Sep 10;737:114-23. Review. No abstract available.

PMID:
7944141
28.

The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein. An overview.

Williams SE, Kounnas MZ, Argraves KM, Argraves WS, Strickland DK.

Ann N Y Acad Sci. 1994 Sep 10;737:1-13. Review. No abstract available.

PMID:
7524391
29.

Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1).

Korenberg JR, Argraves KM, Chen XN, Tran H, Strickland DK, Argraves WS.

Genomics. 1994 Jul 1;22(1):88-93.

PMID:
7959795

Supplemental Content

Loading ...
Support Center